Lipid nanoparticles-mRNA based on the consensus sequences of avian coronavirus S1 and N genes protect animals against multiple viral infections
Open Access
- 30 August 2025
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-26
Abstract
Lipid nanoparticles-mRNA play important roles in SARS-CoV-2 infection control. Avian coronavirus infectious bronchitis virus (IBV) comprises eight genotypes with a lack of cross-protection, causing severe economic losses to the poultry industry. Using immunoinformatics methods, five consensus sequence antigens against prevalent IBV strains were designed. Four monovalent lipid nanoparticles-mRNA (GI-19, GI-13, GI-7, GVI-1) and one quadrivalent lipid nanoparticles-mRNA were constructed to develop a broad-spectrum IBV vaccine. The safety and biodistribution of the lipid nanoparticles-mRNA were evaluated in SPF chickens and confirmed that it induced a strong and durable immune response. The lipid nanoparticles-mRNA efficacy in SPF chickens was verified in infection assays with four genotypes of IBV strains, the results showed that immunization with a 10 µg dose provided complete protection for the chickens, while immunization with a 5 µg dose reduced disease severity, organ damage, and mortality, and inhibited viral replication and shedding. Our results indicate that these Lipid nanoparticles-mRNA are immunogenic and protective in preclinical animal models. These data can provide a basis for IBV prevention and control and the development of mRNA vaccines against other prevalent viruses.Keywords
Funding Information
- National Natural Science Foundation of China (32372981, 32302842)
- National Key Research and Development Program of China (2023YFD1800604)
- Forestry Technology Innovation Project of Guangdong Province (2023KJCX028)
- Double First-class Discipline Promotion Project (2023B10564003)
This publication has 67 references indexed in Scilit:
- Isolation of a more aggressive GVI-1 genotype strain HX of the avian infectious bronchitis virusPoultry Science, 2024
- IEDB‐3D 2.0: Structural data analysis within the Immune Epitope DatabaseProtein Science, 2023
- Innate immune mechanisms of mRNA vaccinesImmunity, 2022
- Principles for designing an optimal mRNA lipid nanoparticle vaccineCurrent Opinion in Biotechnology, 2021
- Genetic diversity of avian infectious bronchitis virus in China in recent yearsInfection, Genetics and Evolution, 2018
- Genome characterization, antigenicity and pathogenicity of a novel infectious bronchitis virus type isolated from south ChinaInfection, Genetics and Evolution, 2017
- Phylogenetic and antigenic analysis of avian infectious bronchitis virus in southwestern China, 2012–2016Infection, Genetics and Evolution, 2016
- S1 gene-based phylogeny of infectious bronchitis virus: An attempt to harmonize virus classificationInfection, Genetics and Evolution, 2016
- Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in miceVaccine, 2013
- PCP Consensus Sequences of Flaviviruses: Correlating Variance with Vector Competence and Disease PhenotypeJournal of Molecular Biology, 2010